Research Paper Volume 15, Issue 17 pp 8833—8850
Comprehensive analysis of ICD-related lncRNAs in predicting risk stratification, clinical prognosis and immune response for breast cancer
Figure 7. Evaluation of immune therapy response and mutation load characteristics of ICDRLs risk subtypes. (A–C) IPS scores predicting ICDRLs risk subtypes based on the TCIA database. (D) Tumor mutation load score of ICDRLs risk subtypes. (E) Clinical prognosis analysis of high and low mutation load groups based on ICDRLs risk subtypes. (F, G) Assessment of somatic mutation frequency in ICDRLs risk subtypes.